Natarajan Raghunand

Moffitt Cancer Center

Papers

1

Total Citations

5

H-Index

1

About

Dr. Natarajan Raghunand is a leading researcher in cancer imaging and magnetic resonance imaging (MRI) methodology, with a particular focus on prostate cancer. His work bridges advanced imaging techniques and clinical outcomes, notably through the development of MRI-based radiomic pelvimetry. In his highly cited 2022 study, Dr. Raghunand demonstrated how preoperative MRI can predict positive surgical margins after robotic prostatectomy, a critical factor in determining whether patients may benefit from postoperative radiotherapy. This contribution has significant implications for personalizing surgical planning and improving oncologic outcomes. While his citation record reflects the emerging nature of this work, his research is foundational in the growing field of radiomics, where quantitative imaging features are correlated with clinical endpoints. Dr. Raghunand’s expertise also extends to the biophysical and chemical aspects of MRI contrast, including the role of pH and tumor microenvironment in imaging. His work is characterized by a translational approach, moving from bench to bedside to enhance the precision of cancer diagnosis and treatment.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Analysis of MRI radiomic pelvimetry and correlation with margin status after robotic prostatectomy.
5 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Moffitt Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago